Ballentine Partners’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.36M Sell
5,704
-65
-1% -$13.5K 0.02% 305
2026
Q1
$1.22M Sell
5,769
-193
-3% -$41.6K 0.02% 311
2025
Q4
$1.23M Buy
5,962
+58
+1% +$10.9K 0.02% 286
2025
Q3
$927K Buy
5,904
+11
+0.2% +$1.7K 0.01% 343
2025
Q2
$990K Sell
5,893
-252
-4% -$37.4K 0.01% 322
2025
Q1
$847K Buy
6,145
+2,459
+67% +$313K 0.01% 325
2024
Q4
$436K Buy
3,686
+471
+15% +$55K 0.01% 460
2024
Q3
$355K Sell
3,215
-426
-12% -$44.5K 0.01% 534
2024
Q2
$358K Buy
3,641
+403
+12% +$41.1K 0.01% 498
2024
Q1
$362K Buy
3,238
+669
+26% +$72.2K 0.01% 484
2023
Q4
$259K Buy
+2,569
New +$255K 0.01% 548
2023
Q3
Sell
-2,288
Closed -$216K 609
2023
Q2
$216K Buy
+2,288
New +$193K 0.01% 534
2022
Q2
Sell
-4,078
Closed -$231K 445
2022
Q1
$231K Buy
+4,078
New +$218K 0.01% 409

Other funds holding CAH

Ballentine Partners's CAH Position: Q2 2026 in Review

Ballentine Partners reduced its Cardinal Health (CAH) stake by 1.1% in Q2 2026, selling an estimated $13.5K and leaving 5,704 shares worth $1.36M. The position accounts for 0.02% of the portfolio, ranked #305.

Ballentine Partners first reported a position in CAH in Q1 2022 and has held it in 13 quarters since. 218 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Ballentine Partners held 5,704 shares of Cardinal Health worth $1.36M as of Q2 2026.
  • Ballentine Partners sold 65 Cardinal Health shares in Q2 2026, an estimated $13.5K.
  • Cardinal Health made up 0.02% of Ballentine Partners's portfolio in Q2 2026, its #305 holding.
  • Ballentine Partners first reported a position in Cardinal Health in Q1 2022 and has held it in 13 quarters since.
  • 218 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Ballentine Partners's 13F filing for Q2 2026, filed 17 Jul 2026.